124 related articles for article (PubMed ID: 14506958)
21. 1,25-Dihydroxyvitamin D(3) and prostaglandin E(2) act directly on circulating human osteoclast precursors.
Itonaga I; Sabokbar A; Neale SD; Athanasou NA
Biochem Biophys Res Commun; 1999 Oct; 264(2):590-5. PubMed ID: 10529407
[TBL] [Abstract][Full Text] [Related]
22. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
[TBL] [Abstract][Full Text] [Related]
23. Formation of osteoclast-like cells from peripheral blood of periodontitis patients occurs without supplementation of macrophage colony-stimulating factor.
Tjoa ST; de Vries TJ; Schoenmaker T; Kelder A; Loos BG; Everts V
J Clin Periodontol; 2008 Jul; 35(7):568-75. PubMed ID: 18435789
[TBL] [Abstract][Full Text] [Related]
24. Effect of corticosteroids on human osteoclast formation and activity.
Hirayama T; Sabokbar A; Athanasou NA
J Endocrinol; 2002 Oct; 175(1):155-63. PubMed ID: 12379499
[TBL] [Abstract][Full Text] [Related]
25. Gingival fibroblasts are better at inhibiting osteoclast formation than periodontal ligament fibroblasts.
de Vries TJ; Schoenmaker T; Wattanaroonwong N; van den Hoonaard M; Nieuwenhuijse A; Beertsen W; Everts V
J Cell Biochem; 2006 May; 98(2):370-82. PubMed ID: 16440316
[TBL] [Abstract][Full Text] [Related]
26. Calcitonin inhibits osteoclast formation in mouse haematopoetic cells independently of transcriptional regulation by receptor activator of NF-{kappa}B and c-Fms.
Granholm S; Lundberg P; Lerner UH
J Endocrinol; 2007 Dec; 195(3):415-27. PubMed ID: 18000304
[TBL] [Abstract][Full Text] [Related]
27. Infliximab acts directly on human osteoclast precursors and enhances osteoclast formation induced by receptor activator of nuclear factor kappaB ligand in vitro.
Takita C; Fujikawa Y; Itonaga I; Taira H; Kawashima M; Torisu T
Mod Rheumatol; 2005; 15(2):97-103. PubMed ID: 17029043
[TBL] [Abstract][Full Text] [Related]
28. Macrophage colony-stimulating factor increases bone resorption by osteoclasts disaggregated from human fetal long bones.
Edwards M; Sarma U; Flanagan AM
Bone; 1998 Apr; 22(4):325-9. PubMed ID: 9556131
[TBL] [Abstract][Full Text] [Related]
29. Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts.
Woo JT; Nakagawa H; Notoya M; Yonezawa T; Udagawa N; Lee IS; Ohnishi M; Hagiwara H; Nagai K
Biol Pharm Bull; 2004 Apr; 27(4):504-9. PubMed ID: 15056855
[TBL] [Abstract][Full Text] [Related]
30. Expression and role of mannose receptor/terminal high-mannose type oligosaccharide on osteoclast precursors during osteoclast formation.
Morishima S; Morita I; Tokushima T; Kawashima H; Miyasaka M; Omura K; Murota S
J Endocrinol; 2003 Feb; 176(2):285-92. PubMed ID: 12553877
[TBL] [Abstract][Full Text] [Related]
31. Coenzyme q10 regulates osteoclast and osteoblast differentiation.
Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK
J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186
[TBL] [Abstract][Full Text] [Related]
32. IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells.
Kitami S; Tanaka H; Kawato T; Tanabe N; Katono-Tani T; Zhang F; Suzuki N; Yonehara Y; Maeno M
Biochimie; 2010 Apr; 92(4):398-404. PubMed ID: 20045440
[TBL] [Abstract][Full Text] [Related]
33. Cloning and characterization of osteoclast precursors from the RAW264.7 cell line.
Cuetara BL; Crotti TN; O'Donoghue AJ; McHugh KP
In Vitro Cell Dev Biol Anim; 2006; 42(7):182-8. PubMed ID: 16948499
[TBL] [Abstract][Full Text] [Related]
34. Induced osteoclastogenesis by fluoroquinolones in unstimulated and stimulated human osteoclast precursor cells.
Costa-Rodrigues J; Martins EG; Fernandes MH
Bone; 2012 Jul; 51(1):17-27. PubMed ID: 22481084
[TBL] [Abstract][Full Text] [Related]
35. Cellular mechanisms of osteoclast formation and lacunar resorption in giant cell granuloma of the jaw.
Itonaga I; Hussein I; Kudo O; Sabokbar A; Watt-Smith S; Ferguson D; Athanasou NA
J Oral Pathol Med; 2003 Apr; 32(4):224-31. PubMed ID: 12653862
[TBL] [Abstract][Full Text] [Related]
36. Human osteoclast and giant cell differentiation: the apparent switch from nonspecific esterase to tartrate resistant acid phosphatase activity coincides with the in situ expression of osteopontin mRNA.
Connor JR; Dodds RA; James IE; Gowen M
J Histochem Cytochem; 1995 Dec; 43(12):1193-201. PubMed ID: 8537635
[TBL] [Abstract][Full Text] [Related]
37. Effects of continuous calcitonin treatment on osteoclast-like cell development and calcitonin receptor expression in mouse bone marrow cultures.
Ikegame M; Rakopoulos M; Martin TJ; Moseley JM; Findlay DM
J Bone Miner Res; 1996 Apr; 11(4):456-65. PubMed ID: 8992876
[TBL] [Abstract][Full Text] [Related]
38. Characterization of MCSF-induced proliferation and subsequent osteoclast formation in murine marrow culture.
Biskobing DM; Fan X; Rubin J
J Bone Miner Res; 1995 Jul; 10(7):1025-32. PubMed ID: 7484277
[TBL] [Abstract][Full Text] [Related]
39. Yukmijihwang-tang inhibits receptor activator for nuclear Factor-κB ligand-induced osteoclast differentiation.
Shim KS; Ma CJ; Kim DS; Ma JY
J Med Food; 2011 Nov; 14(11):1439-47. PubMed ID: 21883017
[TBL] [Abstract][Full Text] [Related]
40. Direct cell-cell contact between periodontal ligament fibroblasts and osteoclast precursors synergistically increases the expression of genes related to osteoclastogenesis.
Bloemen V; Schoenmaker T; de Vries TJ; Everts V
J Cell Physiol; 2010 Mar; 222(3):565-73. PubMed ID: 19927302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
